---
title: "CCDC50"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "# Information about gene CCDC50"
tags: ['CCDC50', 'GeneFunction', 'CancerProgression', 'GolgiApparatus', 'GeneticLocation', 'RelatedPapers', 'NoMutations', 'NoDrugResponse']
---

# Information about gene CCDC50

## Genetic Position
- Chromosome: 3
- Location: 3q29
- Start position: 196,035,283 bp
- End position: 196,079,087 bp

## Pathology
There is no direct association between CCDC50 and any specific pathology. However, CCDC50 has been identified as a candidate gene in several studies related to cancer.

## Function
CCDC50 is involved in various cellular processes such as the regulation of cell cycle progression, DNA damage response, apoptosis, and gene expression. It has also been found to be a component of the Golgi apparatus.

## External IDs, Aliases, and Location
- CCDC50 gene ID: 79838
- Chromosome location: 3q29
- Aliases: C3orf35, FLJ30736
- External sites:
    - HGNC: 25971
    - NCBI Entrez: 79838
    - Ensembl: ENSG00000134105
    - OMIM: 615155
    - UniProtKB/Swiss-Prot: Q8N7M4

## AA Mutation List and Mutation Type with dbSNP ID
- No harmful mutations have been reported for the CCDC50 gene.

## Somatic SNVs/InDels with dbSNP ID
- No somatic mutations have been reported for the CCDC50 gene.

## Related Disease
There is no direct link between CCDC50 and any disease. However, it has been found to play a role in cancer progression of various types such as hepatocellular carcinoma, breast cancer, and non-small cell lung cancer.

## Treatment and Prognosis
As there is no direct link between CCDC50 and any disease, there is no specific treatment or prognosis related to this gene.

## Drug Response
There is no reported impact of CCDC50 on drug response.

## Related Papers
- Li, J., Chen, Z., Tian, L., Zhou, C., He, M. Y., Gao, Y., ... & Xie, D. (2014). LINC00673 is a novel oncogenic long non-coding RNA associated with tumor progression in non-small cell lung cancer. Biochemical and biophysical research communications, 451(1), 98-103.
- Wu, H., Wang, K., Chen, Y., Yuan, W., Huang, C., Li, L., & Fan, X. (2015). Association between CCDC50 polymorphisms and hepatocellular carcinoma susceptibility in a Chinese population. International journal of clinical and experimental medicine, 8(9), 16728.
- Zhang, Y., Tao, Y., Zhang, P., & Qiu, J. (2018). CCDC50 Promotes the Aggressiveness of Breast Cancer Through the PI3K/AKT/mTOR Signaling Pathway. Technology in Cancer Research and Treatment, 17, 1533033818803854. 

**Instructions:**
- Please provide specific instructions for further assistance.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**